1. Home
  2. MBINM vs IMNM Comparison

MBINM vs IMNM Comparison

Compare MBINM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBINM

Merchants Bancorp

HOLD

Current Price

$25.07

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$20.36

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBINM
IMNM
Founded
N/A
2006
Country
United States
United States
Employees
663
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MBINM
IMNM
Price
$25.07
$20.36
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$32.80
AVG Volume (30 Days)
12.8K
907.5K
Earning Date
N/A
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
N/A
$18.41
Revenue Next Year
N/A
$863.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.00
$5.15
52 Week High
$25.96
$27.65

Technical Indicators

Market Signals
Indicator
MBINM
IMNM
Relative Strength Index (RSI) 39.20 39.82
Support Level $24.81 $18.98
Resistance Level $25.16 $22.57
Average True Range (ATR) 0.19 1.12
MACD -0.04 -0.11
Stochastic Oscillator 16.72 17.98

Price Performance

Historical Comparison
MBINM
IMNM

About MBINM Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: